Molly Lamb
Concepts (380)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscular Dystrophy, Duchenne | 6 | 2022 | 94 | 1.650 |
Why?
| Zika Virus Infection | 6 | 2024 | 154 | 1.370 |
Why?
| Diet | 11 | 2024 | 1204 | 1.320 |
Why?
| Autoimmunity | 8 | 2020 | 860 | 1.210 |
Why?
| Guatemala | 23 | 2024 | 311 | 1.090 |
Why?
| Islets of Langerhans | 6 | 2014 | 790 | 1.060 |
Why?
| Zika Virus | 4 | 2024 | 117 | 1.010 |
Why?
| Dengue | 2 | 2024 | 69 | 0.980 |
Why?
| Rural Population | 14 | 2024 | 512 | 0.910 |
Why?
| Child Development | 4 | 2022 | 453 | 0.910 |
Why?
| Diabetes Mellitus, Type 1 | 12 | 2020 | 3624 | 0.900 |
Why?
| Dengue Virus | 2 | 2024 | 41 | 0.840 |
Why?
| Body Weight | 2 | 2018 | 932 | 0.830 |
Why?
| Growth Disorders | 2 | 2023 | 80 | 0.820 |
Why?
| Body Height | 2 | 2016 | 193 | 0.780 |
Why?
| Influenza, Human | 6 | 2022 | 601 | 0.740 |
Why?
| Child, Preschool | 37 | 2024 | 10450 | 0.740 |
Why?
| Infant | 35 | 2024 | 8992 | 0.730 |
Why?
| Child | 46 | 2023 | 20805 | 0.730 |
Why?
| Head | 1 | 2022 | 95 | 0.720 |
Why?
| Microcephaly | 4 | 2024 | 87 | 0.570 |
Why?
| Child Nutritional Physiological Phenomena | 3 | 2015 | 104 | 0.550 |
Why?
| Dietary Carbohydrates | 2 | 2015 | 152 | 0.520 |
Why?
| Pregnenediones | 1 | 2016 | 22 | 0.510 |
Why?
| Humans | 84 | 2025 | 129116 | 0.500 |
Why?
| Milk | 2 | 2014 | 120 | 0.490 |
Why?
| HLA-DR Antigens | 2 | 2014 | 225 | 0.480 |
Why?
| Carbohydrates | 1 | 2015 | 62 | 0.480 |
Why?
| Prednisone | 1 | 2016 | 236 | 0.480 |
Why?
| Infant, Newborn | 16 | 2024 | 5739 | 0.480 |
Why?
| Carbonic Anhydrases | 2 | 2005 | 14 | 0.480 |
Why?
| Adrenal Cortex Hormones | 1 | 2018 | 519 | 0.470 |
Why?
| Culicidae | 2 | 2005 | 30 | 0.470 |
Why?
| Prospective Studies | 17 | 2024 | 7079 | 0.430 |
Why?
| Viruses | 3 | 2023 | 99 | 0.420 |
Why?
| Body Mass Index | 8 | 2020 | 2266 | 0.420 |
Why?
| Eating | 2 | 2024 | 367 | 0.410 |
Why?
| Disease Progression | 4 | 2015 | 2613 | 0.400 |
Why?
| Oryza | 2 | 2024 | 30 | 0.400 |
Why?
| Infant Food | 2 | 2015 | 65 | 0.400 |
Why?
| Developing Countries | 3 | 2025 | 285 | 0.400 |
Why?
| Sarcoma, Kaposi | 2 | 2023 | 76 | 0.380 |
Why?
| Global Health | 2 | 2025 | 328 | 0.380 |
Why?
| Seroepidemiologic Studies | 5 | 2023 | 156 | 0.380 |
Why?
| Glucocorticoids | 1 | 2016 | 575 | 0.370 |
Why?
| Immunoglobulin G | 3 | 2022 | 846 | 0.370 |
Why?
| Cross-Sectional Studies | 9 | 2025 | 5068 | 0.370 |
Why?
| Male | 43 | 2025 | 63194 | 0.360 |
Why?
| Audiovisual Aids | 1 | 2010 | 13 | 0.360 |
Why?
| Sexual Maturation | 1 | 2010 | 52 | 0.350 |
Why?
| Hyperlipidemias | 1 | 2011 | 126 | 0.350 |
Why?
| Female | 48 | 2025 | 68510 | 0.350 |
Why?
| Hypercholesterolemia | 1 | 2011 | 101 | 0.340 |
Why?
| Pregnancy | 12 | 2024 | 6375 | 0.340 |
Why?
| Overweight | 3 | 2019 | 526 | 0.330 |
Why?
| Antibodies, Viral | 6 | 2023 | 603 | 0.330 |
Why?
| Virus Diseases | 2 | 2022 | 209 | 0.320 |
Why?
| Self Concept | 1 | 2010 | 239 | 0.310 |
Why?
| Carbonic Anhydrase Inhibitors | 2 | 2005 | 14 | 0.310 |
Why?
| Caregivers | 3 | 2021 | 812 | 0.310 |
Why?
| Meningitis, Bacterial | 2 | 2022 | 51 | 0.300 |
Why?
| Glycemic Index | 1 | 2008 | 24 | 0.300 |
Why?
| Delivery, Obstetric | 2 | 2019 | 137 | 0.300 |
Why?
| Obesity | 5 | 2015 | 2863 | 0.300 |
Why?
| Autoantibodies | 5 | 2020 | 1465 | 0.290 |
Why?
| Lipids | 2 | 2011 | 624 | 0.290 |
Why?
| Caliciviridae Infections | 2 | 2018 | 17 | 0.290 |
Why?
| Norovirus | 2 | 2018 | 23 | 0.290 |
Why?
| Interviews as Topic | 1 | 2010 | 715 | 0.290 |
Why?
| Respiratory Tract Infections | 2 | 2022 | 372 | 0.280 |
Why?
| Adipose Tissue | 1 | 2011 | 592 | 0.280 |
Why?
| Viral Vaccines | 2 | 2018 | 94 | 0.280 |
Why?
| Body Composition | 1 | 2011 | 657 | 0.280 |
Why?
| Psychology, Child | 1 | 2007 | 36 | 0.270 |
Why?
| Gastroenteritis | 2 | 2017 | 66 | 0.270 |
Why?
| Genotype | 4 | 2015 | 1832 | 0.270 |
Why?
| Adolescent | 18 | 2022 | 20301 | 0.270 |
Why?
| Mental Health Services | 2 | 2021 | 400 | 0.260 |
Why?
| Surveys and Questionnaires | 8 | 2025 | 5376 | 0.260 |
Why?
| Herpesvirus 8, Human | 2 | 2023 | 59 | 0.260 |
Why?
| Gastrointestinal Tract | 2 | 2019 | 184 | 0.240 |
Why?
| Cohort Studies | 8 | 2022 | 5407 | 0.240 |
Why?
| Ectoparasitic Infestations | 1 | 2024 | 5 | 0.240 |
Why?
| Masks | 2 | 2022 | 59 | 0.240 |
Why?
| Animals, Domestic | 1 | 2024 | 14 | 0.240 |
Why?
| Schools | 4 | 2023 | 439 | 0.230 |
Why?
| Risk Factors | 12 | 2021 | 9767 | 0.230 |
Why?
| Digestive System | 1 | 2004 | 30 | 0.220 |
Why?
| Niacin | 1 | 2024 | 19 | 0.220 |
Why?
| Income | 1 | 2025 | 189 | 0.220 |
Why?
| Culex | 1 | 2023 | 13 | 0.220 |
Why?
| Coinfection | 2 | 2022 | 133 | 0.220 |
Why?
| Young Adult | 14 | 2024 | 12389 | 0.220 |
Why?
| Educational Personnel | 1 | 2023 | 12 | 0.210 |
Why?
| Aedes | 1 | 2023 | 57 | 0.210 |
Why?
| HIV Seropositivity | 1 | 2023 | 119 | 0.210 |
Why?
| Metapneumovirus | 1 | 2022 | 13 | 0.200 |
Why?
| Cross Reactions | 1 | 2022 | 128 | 0.200 |
Why?
| Diarrhea | 2 | 2023 | 177 | 0.200 |
Why?
| Neurodevelopmental Disorders | 1 | 2024 | 155 | 0.200 |
Why?
| Cephalometry | 1 | 2022 | 32 | 0.190 |
Why?
| Prevalence | 8 | 2021 | 2564 | 0.190 |
Why?
| Health Knowledge, Attitudes, Practice | 3 | 2023 | 1275 | 0.190 |
Why?
| Anthropometry | 1 | 2022 | 204 | 0.190 |
Why?
| Parents | 3 | 2023 | 1308 | 0.190 |
Why?
| Erythrocyte Membrane | 2 | 2015 | 49 | 0.190 |
Why?
| Respiratory Syncytial Virus, Human | 1 | 2022 | 68 | 0.190 |
Why?
| Adult | 18 | 2025 | 35510 | 0.180 |
Why?
| Sexually Transmitted Diseases, Viral | 1 | 2021 | 8 | 0.180 |
Why?
| Pandemics | 3 | 2025 | 1491 | 0.180 |
Why?
| Health Literacy | 1 | 2023 | 162 | 0.180 |
Why?
| Cesarean Section | 2 | 2019 | 183 | 0.180 |
Why?
| Family Health | 2 | 2015 | 194 | 0.180 |
Why?
| Lead Poisoning | 1 | 2021 | 19 | 0.180 |
Why?
| Proportional Hazards Models | 3 | 2015 | 1210 | 0.180 |
Why?
| Midwifery | 1 | 2022 | 51 | 0.180 |
Why?
| Respiratory Syncytial Virus Infections | 1 | 2022 | 120 | 0.180 |
Why?
| Meningitis | 1 | 2022 | 80 | 0.180 |
Why?
| Malaria | 1 | 2021 | 58 | 0.180 |
Why?
| Arsenic | 1 | 2021 | 66 | 0.180 |
Why?
| Emergency Responders | 1 | 2021 | 35 | 0.180 |
Why?
| Specimen Handling | 1 | 2022 | 165 | 0.180 |
Why?
| Birth Intervals | 1 | 2020 | 21 | 0.170 |
Why?
| Fatty Acids, Omega-3 | 2 | 2015 | 137 | 0.170 |
Why?
| Lysine | 1 | 2022 | 278 | 0.170 |
Why?
| Molecular Diagnostic Techniques | 1 | 2021 | 97 | 0.170 |
Why?
| Maternal Health Services | 1 | 2022 | 96 | 0.170 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2022 | 816 | 0.170 |
Why?
| Endpoint Determination | 1 | 2020 | 75 | 0.170 |
Why?
| Cesarean Section, Repeat | 1 | 2019 | 11 | 0.170 |
Why?
| Age of Onset | 4 | 2022 | 494 | 0.170 |
Why?
| Refugees | 1 | 2021 | 65 | 0.170 |
Why?
| Vaginal Birth after Cesarean | 1 | 2019 | 25 | 0.170 |
Why?
| Follow-Up Studies | 5 | 2021 | 4915 | 0.170 |
Why?
| Regression Analysis | 1 | 2022 | 984 | 0.170 |
Why?
| Language Tests | 1 | 2019 | 33 | 0.160 |
Why?
| Breast Feeding | 4 | 2015 | 422 | 0.160 |
Why?
| Intensive Care Units, Pediatric | 1 | 2021 | 200 | 0.160 |
Why?
| Sexual Partners | 1 | 2021 | 185 | 0.160 |
Why?
| Language Development Disorders | 1 | 2019 | 45 | 0.160 |
Why?
| Dietary Proteins | 2 | 2013 | 128 | 0.160 |
Why?
| Multiplex Polymerase Chain Reaction | 1 | 2019 | 51 | 0.160 |
Why?
| Motor Skills | 1 | 2020 | 91 | 0.160 |
Why?
| Adolescent Health | 1 | 2019 | 39 | 0.150 |
Why?
| Emergency Service, Hospital | 4 | 2022 | 1973 | 0.150 |
Why?
| Arbovirus Infections | 1 | 2018 | 19 | 0.150 |
Why?
| Social Class | 2 | 2010 | 259 | 0.150 |
Why?
| Pregnancy Complications, Infectious | 1 | 2022 | 364 | 0.150 |
Why?
| Muscular Dystrophies | 1 | 2018 | 39 | 0.150 |
Why?
| Epilepsy | 1 | 2022 | 324 | 0.150 |
Why?
| Public Health Surveillance | 1 | 2018 | 68 | 0.150 |
Why?
| HLA-DQ beta-Chains | 2 | 2015 | 61 | 0.150 |
Why?
| Sexual Behavior | 2 | 2021 | 483 | 0.150 |
Why?
| HLA-DR4 Antigen | 2 | 2015 | 78 | 0.150 |
Why?
| Pregnant Women | 1 | 2019 | 114 | 0.150 |
Why?
| HLA-DR3 Antigen | 2 | 2015 | 80 | 0.150 |
Why?
| Linear Models | 3 | 2023 | 816 | 0.150 |
Why?
| Vaccines | 1 | 2023 | 393 | 0.150 |
Why?
| Sentinel Surveillance | 1 | 2017 | 39 | 0.140 |
Why?
| Medicaid | 1 | 2021 | 437 | 0.140 |
Why?
| Vaccination | 2 | 2023 | 1349 | 0.140 |
Why?
| Celiac Disease | 1 | 2020 | 287 | 0.140 |
Why?
| Sex Factors | 4 | 2010 | 1953 | 0.140 |
Why?
| Cell Phone | 1 | 2017 | 70 | 0.130 |
Why?
| Family Characteristics | 4 | 2021 | 179 | 0.130 |
Why?
| Reproducibility of Results | 5 | 2021 | 3033 | 0.130 |
Why?
| Urban Population | 1 | 2019 | 444 | 0.130 |
Why?
| Micronutrients | 2 | 2007 | 88 | 0.130 |
Why?
| Neonatal Screening | 1 | 2017 | 163 | 0.130 |
Why?
| Fever | 1 | 2017 | 301 | 0.130 |
Why?
| Influenza Vaccines | 1 | 2021 | 536 | 0.130 |
Why?
| Health Resources | 1 | 2017 | 120 | 0.120 |
Why?
| Learning | 1 | 2020 | 396 | 0.120 |
Why?
| Feeding Methods | 1 | 2015 | 6 | 0.120 |
Why?
| F2-Isoprostanes | 1 | 2015 | 15 | 0.120 |
Why?
| Down Syndrome | 1 | 2021 | 471 | 0.120 |
Why?
| Models, Psychological | 1 | 2017 | 307 | 0.120 |
Why?
| Mobile Applications | 1 | 2017 | 159 | 0.120 |
Why?
| Methazolamide | 2 | 2005 | 4 | 0.120 |
Why?
| Oxygen Isotopes | 2 | 2005 | 22 | 0.120 |
Why?
| Acetazolamide | 2 | 2005 | 24 | 0.120 |
Why?
| Histocytochemistry | 2 | 2005 | 81 | 0.120 |
Why?
| Energy Intake | 2 | 2008 | 455 | 0.120 |
Why?
| Nutrition Policy | 1 | 2015 | 56 | 0.120 |
Why?
| District of Columbia | 2 | 2012 | 26 | 0.120 |
Why?
| Food Supply | 1 | 2015 | 72 | 0.110 |
Why?
| Population Surveillance | 1 | 2017 | 428 | 0.110 |
Why?
| Sensitivity and Specificity | 4 | 2022 | 1825 | 0.110 |
Why?
| Walking | 1 | 2018 | 500 | 0.110 |
Why?
| Animals | 8 | 2024 | 34600 | 0.110 |
Why?
| Age Factors | 5 | 2015 | 3120 | 0.110 |
Why?
| Adolescent Behavior | 1 | 2019 | 505 | 0.110 |
Why?
| United States | 9 | 2021 | 13938 | 0.110 |
Why?
| Chickens | 2 | 2024 | 188 | 0.110 |
Why?
| Species Specificity | 2 | 2005 | 570 | 0.110 |
Why?
| Hydrogen-Ion Concentration | 2 | 2005 | 538 | 0.110 |
Why?
| Health Behavior | 1 | 2019 | 740 | 0.100 |
Why?
| Social Support | 1 | 2017 | 586 | 0.100 |
Why?
| Case-Control Studies | 2 | 2021 | 3342 | 0.100 |
Why?
| Seroconversion | 2 | 2023 | 46 | 0.100 |
Why?
| Kenya | 2 | 2023 | 107 | 0.100 |
Why?
| Patient Acceptance of Health Care | 1 | 2018 | 767 | 0.100 |
Why?
| Contact Tracing | 1 | 2012 | 23 | 0.100 |
Why?
| Psychometrics | 3 | 2021 | 685 | 0.100 |
Why?
| Insulin | 2 | 2015 | 2320 | 0.100 |
Why?
| Quality Improvement | 4 | 2022 | 1099 | 0.100 |
Why?
| Disease Susceptibility | 1 | 2014 | 335 | 0.100 |
Why?
| Transportation | 1 | 2012 | 50 | 0.100 |
Why?
| Personal Protective Equipment | 2 | 2022 | 51 | 0.090 |
Why?
| Dose-Response Relationship, Drug | 1 | 2016 | 1945 | 0.090 |
Why?
| School Teachers | 2 | 2021 | 20 | 0.090 |
Why?
| Mass Spectrometry | 2 | 2005 | 660 | 0.090 |
Why?
| Area Under Curve | 2 | 2009 | 282 | 0.090 |
Why?
| Cattle | 1 | 2014 | 962 | 0.090 |
Why?
| Acute Disease | 3 | 2019 | 968 | 0.090 |
Why?
| HLA Antigens | 2 | 2013 | 235 | 0.090 |
Why?
| Patient Compliance | 1 | 2015 | 562 | 0.090 |
Why?
| Tuberculosis, Pulmonary | 1 | 2012 | 137 | 0.090 |
Why?
| ROC Curve | 2 | 2009 | 502 | 0.080 |
Why?
| Nutrition Surveys | 4 | 2015 | 262 | 0.080 |
Why?
| Fetal Weight | 1 | 2009 | 56 | 0.080 |
Why?
| Quality of Life | 2 | 2022 | 2693 | 0.080 |
Why?
| Retrospective Studies | 6 | 2022 | 14571 | 0.080 |
Why?
| HIV Infections | 1 | 2023 | 2710 | 0.080 |
Why?
| Chikungunya Fever | 2 | 2021 | 76 | 0.080 |
Why?
| Stress, Psychological | 1 | 2017 | 1062 | 0.080 |
Why?
| Mycobacterium tuberculosis | 1 | 2012 | 314 | 0.080 |
Why?
| Solanum tuberosum | 1 | 2008 | 7 | 0.070 |
Why?
| Edible Grain | 1 | 2008 | 48 | 0.070 |
Why?
| Feeding Behavior | 1 | 2013 | 618 | 0.070 |
Why?
| Pregnancy in Diabetics | 1 | 2009 | 118 | 0.070 |
Why?
| Diagnostic Errors | 1 | 2009 | 160 | 0.070 |
Why?
| Bias | 1 | 2009 | 195 | 0.070 |
Why?
| Radiographic Image Enhancement | 1 | 2007 | 53 | 0.070 |
Why?
| Feasibility Studies | 1 | 2010 | 862 | 0.070 |
Why?
| Self Disclosure | 1 | 2007 | 62 | 0.070 |
Why?
| Longitudinal Studies | 4 | 2018 | 2715 | 0.070 |
Why?
| Vegetables | 1 | 2008 | 147 | 0.070 |
Why?
| Vitamins | 2 | 2024 | 174 | 0.070 |
Why?
| Gestational Age | 1 | 2009 | 868 | 0.070 |
Why?
| Birth Weight | 1 | 2009 | 499 | 0.060 |
Why?
| Mental Health | 2 | 2023 | 684 | 0.060 |
Why?
| Statistics, Nonparametric | 1 | 2007 | 424 | 0.060 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2013 | 2065 | 0.060 |
Why?
| Weight Gain | 1 | 2009 | 505 | 0.060 |
Why?
| Mammography | 1 | 2007 | 146 | 0.060 |
Why?
| Students | 2 | 2023 | 574 | 0.060 |
Why?
| Multivariate Analysis | 1 | 2009 | 1496 | 0.060 |
Why?
| Risk | 2 | 2021 | 856 | 0.060 |
Why?
| Mental Recall | 1 | 2007 | 184 | 0.060 |
Why?
| Genetic Predisposition to Disease | 2 | 2013 | 2267 | 0.060 |
Why?
| Anaplasma | 1 | 2024 | 2 | 0.060 |
Why?
| Ehrlichia | 1 | 2024 | 3 | 0.060 |
Why?
| Rickettsia | 1 | 2024 | 9 | 0.060 |
Why?
| Bartonella | 1 | 2024 | 7 | 0.060 |
Why?
| Siphonaptera | 1 | 2024 | 14 | 0.060 |
Why?
| Dietary Fats | 1 | 2007 | 301 | 0.060 |
Why?
| Neuropsychological Tests | 2 | 2020 | 1004 | 0.060 |
Why?
| Ticks | 1 | 2024 | 17 | 0.060 |
Why?
| Prognosis | 1 | 2013 | 3788 | 0.060 |
Why?
| Cats | 1 | 2024 | 210 | 0.060 |
Why?
| Dog Diseases | 1 | 2024 | 52 | 0.060 |
Why?
| Nutritional Status | 1 | 2007 | 327 | 0.060 |
Why?
| Tobacco Smoke Pollution | 1 | 2007 | 230 | 0.060 |
Why?
| Hospitals | 2 | 2021 | 632 | 0.060 |
Why?
| Dogs | 1 | 2024 | 366 | 0.050 |
Why?
| Mosquito Vectors | 1 | 2023 | 25 | 0.050 |
Why?
| Aged, 80 and over | 3 | 2023 | 7064 | 0.050 |
Why?
| Magnesium | 1 | 2024 | 151 | 0.050 |
Why?
| Databases, Factual | 2 | 2019 | 1279 | 0.050 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2009 | 563 | 0.050 |
Why?
| Larva | 1 | 2004 | 211 | 0.050 |
Why?
| Pyridoxine | 1 | 2022 | 32 | 0.050 |
Why?
| Vomiting | 1 | 2023 | 128 | 0.050 |
Why?
| Vital Signs | 1 | 2022 | 41 | 0.050 |
Why?
| Cough | 1 | 2023 | 116 | 0.050 |
Why?
| Swine | 1 | 2024 | 745 | 0.050 |
Why?
| Middle Aged | 6 | 2021 | 31074 | 0.050 |
Why?
| Observational Studies as Topic | 1 | 2022 | 109 | 0.050 |
Why?
| Aldehyde Dehydrogenase | 1 | 2022 | 105 | 0.050 |
Why?
| Hospitalization | 2 | 2022 | 2077 | 0.050 |
Why?
| Mammals | 1 | 2023 | 269 | 0.050 |
Why?
| Fermentation | 1 | 2021 | 26 | 0.050 |
Why?
| Food Contamination | 1 | 2021 | 43 | 0.050 |
Why?
| World Health Organization | 1 | 2022 | 110 | 0.050 |
Why?
| Phenotype | 2 | 2022 | 3058 | 0.050 |
Why?
| Methylene Blue | 1 | 2021 | 23 | 0.050 |
Why?
| Equipment Reuse | 1 | 2021 | 14 | 0.050 |
Why?
| Hot Temperature | 1 | 2024 | 364 | 0.050 |
Why?
| Leukocyte Count | 1 | 2022 | 328 | 0.050 |
Why?
| Decontamination | 1 | 2021 | 26 | 0.050 |
Why?
| Attitude | 1 | 2023 | 250 | 0.050 |
Why?
| Mass Screening | 1 | 2009 | 1159 | 0.050 |
Why?
| Influenza A Virus, H3N2 Subtype | 1 | 2021 | 43 | 0.040 |
Why?
| Telephone | 1 | 2021 | 169 | 0.040 |
Why?
| Brazil | 1 | 2021 | 154 | 0.040 |
Why?
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 108 | 0.040 |
Why?
| Immunization | 1 | 2023 | 412 | 0.040 |
Why?
| Lead | 1 | 2021 | 56 | 0.040 |
Why?
| Colorado | 2 | 2021 | 4394 | 0.040 |
Why?
| India | 1 | 2021 | 170 | 0.040 |
Why?
| Diet Surveys | 2 | 2013 | 92 | 0.040 |
Why?
| Immunoglobulin M | 1 | 2022 | 272 | 0.040 |
Why?
| Cluster Analysis | 1 | 2022 | 478 | 0.040 |
Why?
| Longevity | 1 | 2021 | 149 | 0.040 |
Why?
| Translations | 1 | 2020 | 17 | 0.040 |
Why?
| Absenteeism | 1 | 2020 | 49 | 0.040 |
Why?
| Chikungunya virus | 1 | 2021 | 76 | 0.040 |
Why?
| Respiratory Tract Diseases | 1 | 2021 | 150 | 0.040 |
Why?
| Triage | 1 | 2021 | 213 | 0.040 |
Why?
| Parity | 1 | 2019 | 121 | 0.040 |
Why?
| Prenatal Care | 1 | 2022 | 274 | 0.040 |
Why?
| Child Language | 1 | 2019 | 25 | 0.040 |
Why?
| Translating | 1 | 2019 | 38 | 0.040 |
Why?
| Rural Health | 1 | 2019 | 70 | 0.040 |
Why?
| Dengue Vaccines | 1 | 2018 | 9 | 0.040 |
Why?
| Parasites | 1 | 2019 | 39 | 0.040 |
Why?
| Arboviruses | 1 | 2018 | 13 | 0.040 |
Why?
| Pilot Projects | 1 | 2024 | 1567 | 0.040 |
Why?
| RNA, Viral | 1 | 2022 | 617 | 0.040 |
Why?
| Culturally Competent Care | 1 | 2019 | 57 | 0.040 |
Why?
| Thinness | 1 | 2019 | 90 | 0.040 |
Why?
| Blood Glucose | 1 | 2008 | 2096 | 0.040 |
Why?
| Seasons | 1 | 2021 | 498 | 0.040 |
Why?
| Pregnancy in Adolescence | 1 | 2019 | 81 | 0.040 |
Why?
| Proteins | 1 | 2004 | 936 | 0.040 |
Why?
| Anti-Infective Agents | 1 | 2020 | 225 | 0.040 |
Why?
| Chi-Square Distribution | 1 | 2019 | 513 | 0.040 |
Why?
| Rare Diseases | 1 | 2018 | 103 | 0.040 |
Why?
| Pregnancy Outcome | 1 | 2020 | 389 | 0.040 |
Why?
| Vulnerable Populations | 1 | 2019 | 157 | 0.040 |
Why?
| Ambulatory Care | 1 | 2021 | 506 | 0.040 |
Why?
| Choice Behavior | 1 | 2019 | 164 | 0.040 |
Why?
| Mothers | 1 | 2023 | 729 | 0.030 |
Why?
| Altitude | 1 | 2021 | 447 | 0.030 |
Why?
| Child Health | 1 | 2019 | 146 | 0.030 |
Why?
| Medical Records | 1 | 2018 | 170 | 0.030 |
Why?
| Health Surveys | 1 | 2019 | 492 | 0.030 |
Why?
| Glucose | 1 | 2022 | 983 | 0.030 |
Why?
| Internal-External Control | 1 | 2017 | 68 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2022 | 1943 | 0.030 |
Why?
| Research Design | 1 | 2023 | 1040 | 0.030 |
Why?
| Child Behavior | 1 | 2019 | 236 | 0.030 |
Why?
| Telemedicine | 1 | 2025 | 783 | 0.030 |
Why?
| Logistic Models | 1 | 2021 | 1979 | 0.030 |
Why?
| Critical Care | 1 | 2021 | 544 | 0.030 |
Why?
| Risk-Taking | 1 | 2019 | 348 | 0.030 |
Why?
| Life Change Events | 1 | 2017 | 148 | 0.030 |
Why?
| Protective Factors | 1 | 2015 | 92 | 0.030 |
Why?
| Cities | 1 | 2015 | 105 | 0.030 |
Why?
| Data Collection | 1 | 2018 | 650 | 0.030 |
Why?
| Cognition | 1 | 2022 | 1111 | 0.030 |
Why?
| Breast Neoplasms | 1 | 2007 | 2150 | 0.030 |
Why?
| Public Health | 1 | 2018 | 486 | 0.030 |
Why?
| Time Factors | 2 | 2015 | 6518 | 0.030 |
Why?
| Bacteria | 1 | 2019 | 811 | 0.030 |
Why?
| Health Promotion | 1 | 2019 | 717 | 0.030 |
Why?
| Genetic Markers | 1 | 2013 | 339 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2020 | 2739 | 0.020 |
Why?
| Maryland | 1 | 2012 | 44 | 0.020 |
Why?
| Automobiles | 1 | 2012 | 19 | 0.020 |
Why?
| Virginia | 1 | 2012 | 59 | 0.020 |
Why?
| Survival Analysis | 1 | 2015 | 1265 | 0.020 |
Why?
| Tuberculin Test | 1 | 2012 | 36 | 0.020 |
Why?
| Comorbidity | 1 | 2017 | 1546 | 0.020 |
Why?
| Adaptation, Psychological | 1 | 2017 | 615 | 0.020 |
Why?
| Risk Assessment | 1 | 2021 | 3260 | 0.020 |
Why?
| Genetic Association Studies | 1 | 2013 | 361 | 0.020 |
Why?
| Biomarkers | 2 | 2015 | 3896 | 0.020 |
Why?
| Clinical Laboratory Techniques | 1 | 2009 | 94 | 0.020 |
Why?
| Aged | 2 | 2021 | 22083 | 0.020 |
Why?
| Environmental Exposure | 1 | 2012 | 464 | 0.020 |
Why?
| Fatty Acids, Omega-6 | 1 | 2007 | 47 | 0.020 |
Why?
| Research Personnel | 1 | 2009 | 160 | 0.020 |
Why?
| Carotenoids | 1 | 2007 | 38 | 0.020 |
Why?
| Infant Nutritional Physiological Phenomena | 1 | 2007 | 137 | 0.020 |
Why?
| Models, Statistical | 1 | 2009 | 626 | 0.010 |
Why?
| Decision Support Techniques | 1 | 2009 | 405 | 0.010 |
Why?
| Early Detection of Cancer | 1 | 2009 | 372 | 0.010 |
Why?
| Clinical Trials as Topic | 1 | 2007 | 1000 | 0.010 |
Why?
|
|
Lamb's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|